Dr. JANSSENS JULES - neurologie
0809.343.353 · rovalta.com · 26/09/2026
NORMAL SITUATION
Dr. JANSSENS JULES - neurologie
Company — Normal situation.
Strike-off: 08 septembre 2026
Financial year 2025 · Closed on 31/12/2025
Net result59,2 k €+8,0 %over 1 year
Gross margin83,2 k €+8,5 %over 1 year
Equity366,3 k €+19,3 %over 1 year
Overview
Identity
Source · BCE/KBODr. JANSSENS JULES - neurologie is a Private company with limited liability incorporated in 2009.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0809.343.353
- Incorporation
- 23/01/2009
- Legal form
- Private company with limited liability
- Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 17 filingsTrend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 83,2 k € | +8.5% | 76,7 k € | +37.0% | 56 k € | -18.2% | 68,4 k € | +58.9% | 43,1 k € |
| EBITDA | 82,5 k € | +8.3% | 76,2 k € | +37.7% | 55,3 k € | -18.5% | 67,9 k € | +59.5% | 42,6 k € |
| Operating result | 82,1 k € | +8.9% | 75,4 k € | +61.4% | 46,7 k € | -21.4% | 59,4 k € | +72.2% | 34,5 k € |
| Net result | 59,2 k € | +8.0% | 54,8 k € | +77.1% | 31 k € | -22.9% | 40,1 k € | +52.0% | 26,4 k € |
| Balance sheet | |||||||||
| Equity | 366,3 k € | +19.3% | 307 k € | +21.7% | 252,2 k € | -22.7% | 326,4 k € | +14.0% | 286,3 k € |
| Total assets | 373,6 k € | +15.8% | 322,7 k € | +14.9% | 281 k € | -20.3% | 352,4 k € | +20.9% | 291,4 k € |
| Cash | 23,6 k € | -44.7% | 42,6 k € | +141% | 17,7 k € | -78.2% | 80,9 k € | -4.2% | 84,5 k € |
| Debts | 7,4 k € | -52.9% | 15,7 k € | -45.5% | 28,8 k € | +10.6% | 26 k € | +402% | 5,2 k € |
Board of directors
Source · NBB, accounts to 31/12/20231 active · 3 ended
Last known composition, from the accounts closed on 31/12/2023, more than two years before the latest accounts. The mandates shown may have expired.
Active mandates
Julius Janssens
ActiveEnded mandates
JULES JANSSENS
EndedJules Janssens
EndedJules Janssens
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 02/06/2026 | 30/07/2025 | 12/08/2024 | 28/09/2023 | 28/09/2023 | 31/10/2021 |
| General meeting | 18/05/2026 | 27/06/2025 | 25/07/2024 | 26/09/2023 | 26/09/2023 | 24/09/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 17 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 18/05/2026 | 02/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 27/06/2025 | 30/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 25/07/2024 | 12/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 26/09/2023 | 28/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 26/09/2023 | 28/09/2023 | Dutch | |
| Micro model | 31/12/2020 | 24/09/2021 | 31/10/2021 | Dutch | |
| Micro model | 31/12/2019 | 30/09/2020 | 30/11/2020 | Dutch | |
| Micro model | 31/12/2018 | 28/06/2019 | 29/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 29/06/2018 | 28/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 30/06/2017 | 21/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 24/06/2016 | 20/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 26/06/2015 | 07/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/06/2014 | 31/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/06/2013 | 29/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 25/08/2012 | 31/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 09/08/2011 | 30/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 16/07/2010 | 27/07/2010 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active · 3 ended
Last known composition, from the accounts closed on 31/12/2023, more than two years before the latest accounts. The mandates shown may have expired.
Active mandates
Julius Janssens
ActiveEnded mandates
JULES JANSSENS
EndedJules Janssens
EndedJules Janssens
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202559,2 k €↑
- 2024Annual accounts 202454,8 k €↑
- 2023Annual accounts 202331 k €↓
- 2022Annual accounts 202240,1 k €↑
- 2021Annual accounts 202126,4 k €↓
- 2020Annual accounts 202028,2 k €↓
- 2019Annual accounts 201929,7 k €↑
- 2018Annual accounts 201822,1 k €↑
- 2017Annual accounts 201721,1 k €↓
- 2016Annual accounts 201626,1 k €↑
- 2015Annual accounts 201513,2 k €↓
- 2014Annual accounts 201437,5 k €↓
- 2013Annual accounts 201338,3 k €↓
- 2012Annual accounts 201239,9 k €↓
- 2011Annual accounts 201141,7 k €↑
- 2010Annual accounts 201039 k €↓
- 2009Annual accounts 200969,6 k €
- 23/01/2009IncorporationPrivate company with limited liability